| Financial Year |
March 31 2023 |
| Monetary Funds |
333,093,881.79 |
| Held-for-trading Financial Assets |
161,387,335.62 |
| Notes Receivable |
-- |
| Accounts Receivable |
234,398,246.44 |
| Advances to Suppliers |
12,909,425.49 |
| Other Receivables |
7,666,615.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
16,239,493.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,156,710.09 |
| Total Current Assets |
1,207,109,725.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,726,538,187.88 |
| Under-construction Projects |
471,458,064.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
32,008,821.02 |
| R&D expenses |
-- |
| Goodwill |
157,082,129.09 |
| Long-Term Deferred and Prepaid Expenses |
41,446,731.06 |
| Deferred Income Tax Assets |
7,306,998.82 |
| Other Non-Current Assets |
117,849,208.53 |
| Sub-Total of Non-Current Assets |
6,053,523,406.38 |
| Total Assets |
7,260,633,131.59 |
| Short-Term Loans |
1,251,931,119.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
368,659,167.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,855,567.34 |
| Taxes Payable |
35,396,386.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,899,563.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
612,432,888.83 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
2,313,316,383.41 |
| Long-term Loans |
1,398,112,949.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,446,705.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,891,059,853.30 |
| Total Liabilities |
4,204,376,236.71 |
| Paid-In Capital(Or Share Stock) |
328,927,197.00 |
| Capital Surplus |
1,916,527,239.24 |
| Surplus Reserve |
49,705,888.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
756,478,053.57 |
| Minority Stockholder's Interest |
4,618,516.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,051,638,378.42 |
| Owner's Equity（Stockholder's Equity） |
3,056,256,894.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,260,633,131.59 |
